ISSUED ON BEHALF OF REED ELSEVIER PLC AND REED ELSEVIER NV
Reed Elsevier PLC and Reed Elsevier NV announce the following transactions in their securities by their Directors and PDMRs:
1. RELX Group plc LTIP (Long-Term Incentive Plan 2013)
On 2 April 2015, the performance shares set out below were granted in accordance with the LTIP rules.
|
No. of Reed Elsevier PLC performance ordinary shares awarded |
No. of Reed Elsevier NV performance ordinary shares awarded |
Date of vesting of performance shares |
Director |
|
|
|
Erik Engstrom |
119,771 |
82,158 |
2018 |
Nick Luff |
56,423 |
38,704 |
2018 |
|
|
|
|
PDMR |
|
|
|
Ian Fraser |
27,825 |
19,086 |
2018 |
Henry Udow |
30,381 |
20,840 |
2018 |
Vesting of these awards is subject to achievement of performance conditions.
2. RELX Group plc BIP (Bonus Investment Plan 2010)
On 2 April 2015, the conditional matching share awards set out below were granted in accordance with the BIP rules.
|
No. of Reed Elsevier PLC conditional matching ordinary shares awarded |
No. of Reed Elsevier NV conditional matching ordinary shares awarded |
No. of Reed Elsevier PLC conditional matching ADRs awarded |
No. of Reed Elsevier NV conditional matching ADRs awarded |
Date of vesting of conditional matching shares/ADRs |
Director |
|
|
|
|
|
Erik Engstrom |
- |
- |
- |
31,732 |
2018 |
Nick Luff |
28,187 |
19,194 |
- |
- |
2018 |
|
|
|
|
|
|
PDMR |
|
|
|
|
|
Ian Fraser |
38,493 |
- |
- |
- |
2018 |
Henry Udow |
21,014 |
7,155 |
2,540 |
- |
2018 |
Note: Each Reed Elsevier PLC ADR represents 4 Reed Elsevier PLC ordinary shares and each Reed Elsevier NV ADR represents 2 Reed Elsevier NV ordinary shares.
Vesting of these awards is subject to achievement of performance conditions.
3. RELX Group plc ESOS (Executive Share Option Scheme 2013)
On 2 April 2015, the market price options and conditional share awards set out below were granted in accordance with the ESOS rules.
|
No. of Reed Elsevier PLC ordinary shares under option granted with an exercise price of £11.52 per share |
No. of Reed Elsevier NV ordinary shares under option granted with an exercise price of €23.075 per share |
No. of Reed Elsevier PLC conditional ordinary shares awarded |
No. of Reed Elsevier NV conditional ordinary shares awarded |
Director |
|
|
|
|
Erik Engstrom |
119,771 |
82,158 |
- |
- |
Nick Luff |
56,423 |
38,704 |
- |
- |
|
|
|
|
|
PDMR |
|
|
|
|
Ian Fraser |
10,702 |
7,341 |
2,140 |
1,468 |
Henry Udow |
11,685 |
8,015 |
2,337 |
1,603 |
Note: The options are exercisable between 2018 and 2025, and the conditional share awards vest in 2018.
Vesting of options awarded to Directors is subject to achievement of performance conditions.
The conditional share awards under ESOS were granted pursuant to elections by these PDMRs to receive half of their 2015 ESOS award in the form of conditional shares.
4. RELX Group plc Executive Share Option Scheme: Exercise of options and sale of shares
On 2 April 2015, Erik Engstrom exercised options granted on 5 May 2011 to acquire 139,146 Reed Elsevier PLC ordinary shares and 92,953 Reed Elsevier NV ordinary shares at option prices per share of £5.39 and €8.969 respectively. All of the ordinary shares acquired on exercise were sold at the prices shown below.
No. of Reed Elsevier PLC ordinary shares |
No. of Reed Elsevier NV ordinary shares |
Sale price |
2,782 |
- |
£11.55 |
136,364 |
- |
£11.5189 |
- |
1,859 |
€23.0557 |
- |
91,094 |
€23.0087 |
Following these transactions, the current interests of Erik Engstrom and Nick Luff in the share capital of Reed Elsevier PLC and Reed Elsevier NV are:
|
No. of Reed Elsevier PLC ordinary shares |
No. of Reed Elsevier NV ordinary shares |
Director |
|
|
Erik Engstrom |
127,040 |
521,556 |
Nick Luff |
67,534 |
47,616 |
- ENDS -
Enquiries
Paul Abrahams (Media)
+44 20 7166 5724
Colin Tennant (Investors)
+44 20 7166 5751